Relatively weak magnets in consumer products have always posed some risk, usually very low, to the function of pacemakers and implantable cardioverter-defibrillators (ICDs). However, stronger ...

Coming up with a way to safely recondition the pacemakers — and launching a trial to test the idea — was just one part of the process, said Crawford. The team also had to get ethical and ...

The AVEIR device is different from traditional pacemakers in part because it has no leads or cords and is absorbed by the heart. It is also 10 times smaller than a traditional pacemaker.

part of the Medical Devices segment. After the announcement yesterday, Abbott shares edged up 0.6%, finishing at $113.29. The AVEIR leadless pacemaker remains one of the key drivers of the Rhythm ...